The PROOF Trial - Prospective, Open-label, Multicenter, Non-randomized Investigation on Percutaneous Patent Foramen Ovale (PFO) Closure Using the Occlutech PFO Occluder to Prevent Recurrence of Stroke in Patients With Cryptogenic Stroke and High Risk PFO
Conditions: Stroke; PFO - Patent Foramen Ovale Intervention: Device: Occlutech PFO Occluder Sponsor: Occlutech International AB Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials